PX1 Research provides fully verified Sermorelin with COA documentation for every batch shipped to academic and institutional laboratories. Access independent third-party analytical data detailing purity, identity, and molecular integrity for your in vitro and preclinical research protocols.
PX1 Research provides fully verified Sermorelin with COA documentation for every batch shipped to academic and institutional laboratories. Access independent third-party analytical data detailing purity, identity, and molecular integrity for your in vitro and preclinical research protocols.
A **Sermorelin COA** (Certificate of Analysis) is an essential analytical document verifying the chemical identity, structural purity, and safety profile of synthetic Sermorelin acetate. Research facilities require a lot-specific **Sermorelin with COA** to confirm peptide purity exceeds 99% via Reverse-Phase HPLC, rule out heavy metals, verify exact molecular weight via Mass Spectrometry, and validate sub-threshold endotoxin levels prior to initiating in vitro or preclinical animal studies.
Without verifiable analytical documentation, laboratory personnel risk experimental variance caused by residual counter-ions, truncated peptide fragments, or bacterial endotoxins. PX1 Research mandates that every batch of Sermorelin Acetate undergoes third-party testing in an ISO 17025 accredited analytical facility prior to distribution. This ensures that quantitative data in baseline cellular assays remain reproducible across experimental runs.
To maintain rigorous scientific standards, PX1 Research evaluates all research peptides against defined quality parameters. When reviewing a **Sermorelin COA**, principal investigators should inspect specific criteria to confirm compound integrity before introducing samples into test systems.
• **Purity Verification:** Minimum 99% purity confirmed via analytical Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). • **Mass Identifiers:** Exact monoisotopic mass confirmation via Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) or Electrospray Ionization Mass Spectrometry (ESI-MS). • **Endotoxin Quantitation:** Limulus Amebocyte Lysate (LAL) testing guaranteeing endotoxin levels below 0.01 EU/mg to eliminate non-specific inflammatory signaling in cell culture models. • **Manufacturing Origin:** Synthesized in US-based, GMP-compliant facilities adhering to strict solid-phase peptide synthesis (SPPS) controls. • **Lot Traceability:** Individual lot numbers assigned to each vial matching the analytical reports provided by independent testing labs. • **Fulfillment Integrity:** Cold-chain ready packaging dispatched with same-day shipping (Monday–Friday) from facility hubs in California and Arizona.
Sermorelin acetate is a synthetic 29-amino-acid peptide corresponding to the amino-terminal segment of endogenous Growth Hormone-Releasing Hormone (GHRH 1-29). In preclinical models, GHRH 1-29 retains full biological activity of the native 44-amino-acid hypothalamic hormone. Its primary chemical structure consists of the sequence Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2.
In vitro binding assays demonstrate that Sermorelin selectively targets the GHRH receptor (GHRHR) located on pituitary somatotropes. Upon receptor activation, intracellular signal transduction proceeds via a G-protein-coupled pathway, stimulating adenylyl cyclase and increasing cyclic adenosine monophosphate (cAMP) accumulation. Preclinical studies suggest that this cascade triggers the transcription and pulsatile release of endogenous growth hormone. Researchers investigating growth hormone secretagogues utilize Sermorelin to analyze receptor affinity, downstream kinase activation, and receptor desensitization kinetics without the confounding systemic feedback mechanisms observed with full-length growth hormone administration.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold-standard method for quantifying chemical purity in synthetic peptides. During RP-HPLC analysis, a sample of Sermorelin is loaded onto a hydrophobic stationary phase column and eluted using a binary gradient system (typically acetonitrile and water containing 0.1% trifluoroacetic acid).
The resulting chromatogram displays peak area percentages. A compliant **Sermorelin COA** features a sharp, dominant central peak representing the intact 29-amino-acid peptide, with minor secondary peaks (representing deletion sequences or residual protecting groups) accounting for less than 1% of the total integrated area. Researchers can review detailed technical breakdowns in our guide on HPLC purity testing to better analyze chromatogram baseline stability and resolution parameters.
While HPLC isolates and measures the abundance of chemical species, Mass Spectrometry (MS) confirms molecular identity. The calculated molecular weight of Sermorelin free base is approximately 3357.88 Da (with the acetate salt form shifting total mass accordingly).
On an authentic **Sermorelin COA**, Electrospray Ionization (ESI-MS) spectra display distinct mass-to-charge (m/z) ratio peaks corresponding to the single, double, and triple-protonated forms of the molecule. The observation of an observed mass matching the theoretical value within a ±0.5 Da margin confirms correct primary synthesis without amino acid deletions, side-chain modifications, or sequence truncations. This verification is critical when conducting comparative studies alongside other GHRH analogs such as CJC-1295 No DAC.
Bacterial endotoxins, primarily lipopolysaccharides (LPS) derived from Gram-negative outer cell membranes, can invalidate cell culture data by triggering toll-like receptor 4 (TLR4) activation. In immunological and cellular signaling studies, even picogram quantities of contaminating endotoxin induce artifactual cytokine production.
PX1 Research subjects every batch of **Sermorelin with COA** to kinetic chromogenic LAL testing. Establishing strict thresholds below 0.01 EU/mg guarantees that experimental responses measured during in vitro assays reflect genuine peptide-receptor interactions rather than immune responses triggered by bacterial contaminants. Detailed specifications on bio-burden limits are available in our technical brief on endotoxin testing standards.
Within the domain of secretagogue research, investigators frequently evaluate multiple GHRH derivatives and GHS receptor agonists to compare binding affinity, signal duration, and enzymatic stability. Understanding structural variations helps laboratories select appropriate compounds for targeted research models.
Sermorelin represents the shortest functional fragment (GHRH 1-29) of native GHRH. In contrast, Tesamorelin incorporates a trans-3-hexenoic acid modification at the N-terminus, which enhances resistance to dipeptidyl peptidase-4 (DPP-IV) cleavage in enzymatic stability assays. Similarly, CJC-1295 No DAC contains four substituted amino acids that extend its terminal half-life in rodent models. When exploring synergistic pathways, researchers often pair GHRH analogs with selective ghrelin mimetic peptides like Ipamorelin or GHRP-2 to observe dual-receptor co-stimulation phenomena in isolated cell lines.
Synthetic Sermorelin acetate is supplied as a lyophilized (freeze-dried) cake to preserve chemical stability during storage and transport. Reconstitution must be performed under sterile laboratory conditions using appropriate solvent media tailored to the target research application.
For standard analytical and cellular assays, reconstitution with sterile bacteriostatic water for research (0.9% benzyl alcohol) or sterile 0.9% sodium chloride solution is standard practice. The lyophilized powder should be reconstituted by allowing the solvent to flow gently down the inner glass wall of the vial, followed by low-speed swirling. Vigorous agitation or vortexing must be avoided to prevent mechanical shearing of the peptide chain. Laboratory personnel should refer to our detailed reconstitution protocols for specific concentration calculations and pH buffering recommendations.
Lyophilized Sermorelin should be stored at -20°C upon receipt to maintain long-term stability. Under desiccation at sub-zero temperatures, the un-reconstituted compound remains stable for extended periods without significant hydrolysis or oxidation.
Following reconstitution, liquid aliquots should be maintained at 2°C to 8°C for short-term experimentation (use within 14–28 days depending on solvent antibacterial preservation) or frozen at -80°C for long-term storage. Repeated freeze-thaw cycles must be strictly avoided, as thermal fluctuations promote peptide aggregation and precipitation out of solution. All storage parameters should be logged into the laboratory inventory system alongside the corresponding lot number from the **Sermorelin COA**.
Academic institutions, biotechnology organizations, and contract research organizations (CROs) demand stringent batch consistency when procuring compounds for high-throughput screening or multi-phase rodent trials. Accessing full analytical testing packages prior to purchase eliminates supply-chain uncertainty.
PX1 Research supports institutional procurement through our wholesale lab account portal. Institutional buyers receive lot-matched COAs, standardized batch documentation, and direct access to analytical chemists to review raw HPLC/MS spectral data files. Every order is fulfilled directly from US warehouses in California and Arizona, ensuring rapid delivery and immediate cold-storage check-in.
What is a sermorelin coa?
A Sermorelin COA (Certificate of Analysis) is a official laboratory document generated by an independent, third-party analytical facility. It details the precise chemical identity, purity percentage (verified by RP-HPLC), molecular weight (verified by Mass Spectrometry), and endotoxin levels for a specific lot of synthetic Sermorelin acetate.
Why is ordering sermorelin with coa important for research?
Ordering Sermorelin with COA guarantees that the compound used in cellular or animal models meets defined chemical standards. Unverified peptides may contain synthesis byproducts, incorrect sequences, or endotoxin contamination that alter experimental outcomes and compromise data reproducibility.
How does PX1 Research test every lot of Sermorelin?
Every lot of Sermorelin synthesized for PX1 Research undergoes rigorous third-party analytical testing, including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity, Mass Spectrometry (ESI-MS/MALDI-TOF) for identity verification, and Limulus Amebocyte Lysate (LAL) testing for endotoxin quantitation.
What purity level is documented on a PX1 Sermorelin COA?
PX1 Research requires a minimum purity threshold of 99% as confirmed by RP-HPLC integration for all Sermorelin batches released for laboratory research.
What is the theoretical molecular weight shown on a Sermorelin COA?
The theoretical molecular weight of Sermorelin free base (GHRH 1-29 amide) is 3357.88 Da. The COA mass spectrum confirms that the observed mass matches this theoretical target within standard analytical tolerances.
What endotoxin levels are reported on a Sermorelin COA?
A compliant PX1 Sermorelin COA reports endotoxin levels below 0.01 EU/mg, ensuring the material is suitable for sensitive in vitro assays and receptor binding studies without causing non-specific inflammatory signaling.
Where are PX1 Sermorelin research compounds manufactured and shipped from?
PX1 Research compounds are manufactured in US-based, GMP-compliant facilities. Orders are fulfilled directly from warehouse hubs in California and Arizona with same-day shipping available Monday through Friday.
How should reconstituted Sermorelin be stored in the laboratory?
Reconstituted Sermorelin solution should be stored at 2°C to 8°C for short-term use (up to 28 days in bacteriostatic media) or aliquoted and stored at -80°C for long-term storage to prevent peptide degradation and avoid repeated freeze-thaw cycles.
How does Sermorelin differ structurally from CJC-1295?
Sermorelin represents the exact native 29-amino-acid sequence of GHRH (1-29), whereas CJC-1295 contains specific amino acid substitutions (such as D-Ala, Gln, Ala, and Leu modifications) designed to resist enzymatic degradation by DPP-IV in preclinical research models.
Can institutional laboratories request lot-specific raw analytical data for Sermorelin?
Yes. Institutional accounts and qualified research labs can request raw chromatograms, mass spectra files, and extended batch analysis records through the PX1 Research technical support team or via our wholesale account portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.